Formulation and Comparative Evaluation of
Aceclofenac Oral Disintegrating Tablets Using Natural Disintegrants
Narendra Babu K.*, Imran Khan Pathan
Department of Pharmaceutics, Krishna Teja Pharmacy College, Renigunta
Road- 517520 Tirupati, Andhra Pradesh, India.
ABSTRACT:
In recent years, plant derived polymers have evoked tremendous
interest due to their diverse pharmaceutical applications such as diluents,
binder, disintegrant in tablets, thickeners in oral
liquids, protective colloids in suspensions, gelling agents in gels and bases
in suppository. The main objective of present study was to formulate
Aceclofenac oral disintegrating tablets using different natural gums and
mucilage’s and to study their functionality as disintegrating agents for oral
disintegrating tablets. Physicochemical properties and acute toxicity studies
of dried powders of isolated mucilage’s were studied. Dispersible tablets of
Aceclofenac were prepared by direct compression method using different natural disintegrants and Sodium Starch Glycolate.
The evaluation parameters revealed that the formulated tablets had good
appearance and better drug release properties. The study revealed that natural disintegrants were effective as super disintegrant.
KEYWORDS: Aceclofenac, Disintegrant, Oral disintegrating tablets, Sodium
starch glycolate.
INTRODUCTION:
Mucilage’s and Gums are most commonly
used as adjuvant in the manufacturing of different pharmaceutical dosage forms.
They possess a variety of pharmaceutical properties, which include binding,
disintegrating, suspending, emulsifying and sustaining properties at different
proportion in different pharmaceutical dosage forms (1). Natural
mucilage’s and gums are preferred over semi-synthetic and synthetic materials
due to their non-toxic, low cost, free availability, emollient and
non-irritating nature. The present work was carried out to study the disintegrant property of Annona
squamosa
L leaves mucilage, Leucaena leucocephala bark gum, Moringa
oleifera bark gum and Loctus
Bean gum in comparison with Sodium Starch Glycolate
by formulating oral disintegrating tablets of Aceclofenac.
Many patients express difficulty in swallowing tablets and hard gelatin
capsules, tending to non-compliance and ineffective therapy. Recent advances in
novel drug delivery systems (NDDS) aim to enhance safety and efficacy of drug
molecule by formulating a convenient dosage form for administration and to
achieve better patient compliance. One such approach is fast disintegrating
tablets. Aceclofenac is a novel
non-steroidal anti-inflammatory drug (NSAID) having anti-inflammatory and
analgesic properties and is widely used in the treatment of rheumatoid
arthritis, osteoarthritis and ankylosing spondylitis(2).
The concept of formulating oral
disintegrating tablets containing Aceclofrenac offers
a suitable and practical approach in serving desired objective of faster
disintegration and dissolution characteristics with potential increased
bioavailability.
MATERIALS
AND METHODS:
Aceclofenac (SR
Drugs and Intermediates Pvt Ltd, Hyderabad). The leaves of Annona squamosa. L, Leucaena
leucocephala bark gum and Moringa
oleifera bark gum were collected from trees
locally. Loctus bean gum (LBG) (Olin chemicals,
Mumbai, India), Sodium starch glycolate (SSG) (DMV International) Micro crystalline cellulose (MCC) (Mylochem, Mumbai, India), Mannitol
(Thermo Fisher Scientific India Pvt Ltd, Mumbai,
India), Talc (Kemphasol, Mumbai, India), Magnesium stearate (MS) (S.D. Fine Chem. Limited, Mumbai, India). All
other solvents and chemicals were of analytical-reagent grade. Distilled water
was used throughout the study.
Extraction of Annona sqamosa L
leaves mucilage (ASLM):
The fresh leaves
of Annona sqamosa L was collected and washed with
water to remove dirt and debris. The leaves were chopped and soaked in water
for 5–6 h, boiled for 30 min, and kept aside for 1 h for complete release of
the mucilage into water. The material was squeezed from an eight‐fold muslin cloth bag to remove the marc
from the solution. Alcohol in a quantity of three times the volume of the total
filtrate was added to the filtrate to precipitate the mucilage. The mucilage
was separated, dried in an oven at a temperature < 50 °C, collected, dried‐powdered passed through a sieve (number
80), and stored in desiccators, until further use (3, 4).
Extraction of Lacuenae lucopholia bark gum (LLBG):
LLBG was obtained
from the bark of Leucaena leucocephala
trees grown around locally. The gum was collected around mid- February during
the day time. For the processing of the gum, the method of Femi- Oyewo et al, was adopted with some
modifications. The gum was dried in an oven at 40°C for 2 h and size reduced
using a blender. It was hydrated in double strength chloroform water for 5 days
with intermittent stirring to ensure complete dissolution and then, strained
through a fourfold muslin cloth to obtain particulate free slurry which was
allowed to sediment. Thereafter, the gum was precipitated from the slurry using
absolute ethanol, filtered and defatted with diethyl ether. The precipitate was
dried in the oven at 40°C for 48 h. The dried flakes were pulverized using a
blender and stored in an air tight container (4).
Extraction of Moringa oleifera bark gum (MOBG):
The gum was
collected from trees (Injured site). It was dried, ground and passed through
sieve no 80. Dried gum was stirred in distilled water for 6-8 hours at room
temperature and subjected for centrifugation at 2000 rpm for 5 min. The
supernatant liquid was separated and the residue is further washed 2 – 3 times
with water and added to the supernatant liquid. To this twice the quantity of
acetone is added with continuous stirring until the gum gets precipitated. The
precipitated material was washed with distilled water and dried at 50- 600C
and stored in desiccators until further use (5, 6).
Physicochemical Properties of
Dried Powdered Extracts:
Dried powdered Annona squamosa L Leaves mucilage, Leucaena leucocephala bark gum, Moringa oleifera bark gum and Loctus Bean gum were studied for percentage yield, colour, pH of solutions.
Acute
Toxicity Studies for Extracts:
Experiments were
performed complied with the rulings of the Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA) New Delhi, India, and the
study was permitted by the institutional ethical committee of the Krishna Teja Pharmacy College, Tirupati,
India. Male albino mice weighing
20-35gm were used for the study according to the OECD guide lines 423 (7). The dose of 2000mg/kg
body weight p.o of ASLM, LLBG, MOBG and LBG were
administered to overnight fasted mice’s. Food was withheld for a further 3-4
hours after administration of and observed for signs for toxicity.
Compatibility Study Drug-Excepient by IR
Spectroscopy:
The samples of Aceclofenac (drug) and drug + excipients
(disintegrants) were prepared in to pellets using
Potassium Bromide at ratio (1: 100) and standard pure Potassium Bromide
subjected for scanning from 3500 cm-1 to 500 cm-1 using IR spectrophotometer.
Physical Properties of Pre-compressed Formulations:
The physical properties such as angle of
repose, bulk density, tapped density, Compressibility Index (Carr’s
Consolidation Index) and Hausner Ratio were been
evaluated for all the formulations (8).
Formulation of Aceclofenac ODT’S:
Dispersible tablets of Aceclofenac were prepared by the
conventional direct compression technique using ASLM, LLBG, MOBG, LBG and SSG as disintegrants. All the required ingredients as per the
formulation table were weighed and passed through Size 40# sieve. The Mixture
was then blended for 15 mins. The blend was then
compressed on a Cadmach 16 stage punch machine(9, 10, 11). The composition of
each formulation is given in table 1.
TABLE
1. FORMULATIONS FOR PREPARATION OF ACE- ODT’S:
S. NO |
INGREDIANTS (mg) |
FORMULATIONS |
||||
F1 |
F2 |
F3 |
F4 |
F5 |
||
1 |
Aceclofenac |
10 |
10 |
10 |
10 |
10 |
2 |
Mannitol |
12 |
12 |
12 |
12 |
12 |
3 |
MCC |
150 |
150 |
150 |
150 |
150 |
4 |
ASLM |
10 |
- |
- |
- |
- |
5 |
LLBG |
- |
10 |
- |
- |
- |
6 |
MOBG |
- |
- |
10 |
- |
- |
7 |
LBG |
- |
- |
- |
10 |
- |
8 |
SSG |
- |
- |
- |
- |
10 |
9 |
Talc |
9 |
9 |
9 |
9 |
9 |
10 |
MS |
9 |
9 |
9 |
9 |
9 |
TOTAL |
200mg |
200mg |
200mg |
200mg |
200 mg |
ACE- ODT’S –
Aceclofenac oral disintegrating tablets
Evaluation of ODT’S:
Tablets were evaluated for hardness, weight variation, thickness,
diameter, friability, drug content, wetting time, disintegrating time, moisture
uptake studies and stability studies. The Monsanto hardness tester and Roche friabilator were used to test hardness and friability loss
respectively. In weight variation test, twenty tablets were selected at random
and average weight was determined using electronic balance (Shimadzu
Philippines Manufacturing INC). Thickness and diameter of tablets were
determined by using Verniear calliperus
(Atlas Tools Center, Chennai, India). To determine drug content of tablets, twenty tablets were weighed and powdered. An
amount of the powder equivalent to 10mg of Aceclofenac was dissolved in 10ml of
pH 7.4 PBS, filtered, diluted suitably and estimated for the drug content at
274 nm using UV-Visible spectrophotometer (UV -Analytical Technologies
Limited). To measure wetting time of
tablet, a piece of tissue paper was folded twice and placed in a small Petri
dish containing sufficient water. A tablet was kept on the paper and the time
for complete wetting of tablet was measured. Disintegrating time was determined
using USP tablet disintegrating test apparatus (Thermonic,
Campbell Electronics, Mumbai, India) using 900 ml of distilled water at 37o
c.
Dissolution
studies:
In- vitro drug release studies of all the
formulations were carried out using tablet dissolution test apparatus (Electrolad (USD) Model- TDT08L) at 75rpm. Phosphate buffer
(PBS) pH 7.4 was used as the dissolution media with temperature maintained at
37±0.5şC. Samples were withdrawn at different time intervals and analyzed at
274nm for percentage drug release using Analytical Technologies Limited
UV-Visible spectrophotometer. The sample after each withdrawal was replaced
with same volume of fresh media (12, 13).
Moisture
uptake studies:
Ten tablets from
each formulation were kept in a dessicator over
calcium chloride at 370C for 24h. The tablets were then weighed and
exposed to 75% relative humidity, at room temperature for 2 weeks. Required
humidity was achieved by keeping saturated sodium chloride solution at the
bottom of the dessicator for 3 days. One tablet as
control (without super disintegrants) was kept to
assess the moisture uptake due to other excipients.
Tablets were weighed and the percentage increase in weight was recorded (14).
Stability Studies:
Stability studies were carried out at 40oC ± 2oC
/ 75% RH ± 5% RH for a period of six months. The tablets were stored in High
density Polyethylene (HDPE) containers and evaluated at 3rd month
for the changes in hardness, Weight variation, thickness, diameter, friability,
drug content and dissolution at 15 min.
RESULTS AND DISCUSSION:
The extracts of ASLM, LLBG and MOBG
were extracted and purified. The percentage yield of extracts was 10.2, 79.41 and
84.5% respectively. The colours of ASLM, LLBG, MOBG and
LBG were green, brown, dark brown, creamy white respectively and pH values are
6.3, 4.2, 5.9 and 5.8 respectively. The acute toxicity studies evaluated in albino mice’s not showed
any mortality and other side effects. The compatability
studies on drug- excepient by IR spectroscopy had
shown no interactions. The IR spectra are shown in figures 1 to 11. The angle of repose was found
to be in the range of 29.980 to 31.440, which indicates
moderate flow. Bulk density and tapped density varied from 0.472 gm/cc to 0.486
gm/cc and 0.582 gm/cc to 0.593 gm/cc respectively. The percentage
compressibility is within the range of 18.04% to 19.28% and the Hausner ratio is within the range of 1.22 to 1.238, which
indicates flow of powder is fair in flow. The average hardness of all the
batches is in the range of 2.51 to 2.68Kg/cm2 and possesses
sufficient hardness. As the % weight variation was within the limits of ± 7.5%
USP in range from 204±7.37 to 208.4± 5.67 mg. The thickness and diameter for
all formulations are within the limits. The % friability is in the range of
0.543 % to 0.711 %, which was found to be in limit. The drug content is in the
range of 99.87±0.151 to 102.44±0.939 %. The
wetting is in the range of 23 to 136.3. The disintegrating time is in the range
of 7.96 to 64.86 sec. The results were shown in the table 2.
Figure: 1.IR spectra of
Aceclofenac
Figure: 2.IR spectra of Annona sqamosa L
leaves mucilage
Figure: 3.IR spectra of Annona sqamosa L
leaves mucilage + Aceclofenac
Figure: 4.IR spectra of Leucaena leucocephala
bark gum
Figure: 5.IR spectra of Leucaena oeucocephala
bark gum + Acecofenac
Figure: 6.IR spectra of Moringa oleifera bark
gum
Figure: 7.IR spectra of Moringa oleifera bark
gum + Aceclofenac
Figure: 8.IR spectra of Loctus Bean gum
Figure: 9.IR spectra of Loctus Bean gum + Aceclofenac
Figure: 10.IR spectra of
Sodium starch glycolate
Figure: 11.IR spectra of
Sodium starch glycolate + Aceclofenac
Figure: 12. Comparative in-vitro% drug release for F1, F2, F3,
F4, F5 formulations
Tablets of all formulations achieved 100% drug release with in 15
min and met the requirements of in vitro
dissolution. But the rate of release of drug is faster in formulations
F1, F3 and F4 comparable to F5 formulation. The results are shown in table 3
and figure 12. The moisture uptake studies shown that formulation F1 absorbed
more moisture then all other formulations when compared with control (without
disintegrating agent). The stability studies had shown no magnificent change in
the evaluation parameters after 3 months at (40oC ± 2oC /
75% RH ± 5% RH). The results of stability studies were shown in table 4.
TABLE 2. EVALUATION OF FORMULATED
ODT’S
S.NO |
PARAMETER |
FORMULATIONS |
||||
F1 |
F2 |
F3 |
F4 |
F5 |
||
1 |
Hardness**
(Kg/cm2) |
2.68± 0.109 |
2.58± 0.192 |
2.51± 0.2 |
2.59± 0.151 |
2.51± 0.1 |
2 |
Weight variation***
(mg) |
206.2±6.99 |
204±7.37 |
205.9±6.32 |
208.4± 5.67 |
206.1± 6.99 |
3 |
Thickness*
(mm) |
2.18 ±0.216 |
2.19± 0.114 |
2.19± 0.089 |
2.18± 0.089 |
2.19± 0.228 |
4 |
Diameter*
(cm) |
1.1 ± 0 |
1.13 ± 0.04 |
1.1 ± 0 |
1.13 ± 0.02 |
1.1 ± 0 |
5 |
Friability**
(%) |
0.711 ±0.007 |
0.543 ±0.42 |
0.65±0.021 |
0.574 ±0.014 |
0.69 ±0.028 |
6 |
Drug content***
(%) |
101.14 ±0.17 |
99.87 ± 0.151 |
102.44 ± 0.939 |
102.21 ± 0.095 |
100.07 ± 0.646 |
7 |
Wetting time*
(sec) |
23 ± 2 |
114.6± 2.51 |
30.6 ± 2.08 |
136.3±3.21 |
24.6 ± 1.15 |
8 |
Disintegrating
time* (sec) |
7.96 ± 0.4163 |
37.03 ± 0.2517 |
12.86 ± 0.3215 |
64.86 ± 0.8083 |
9.0 ± 0.3 |
ODT’S - Oral
disintegrating tablets.
The data represented as mean ± SD (*n -
5, **n - 10, ***n – 20)
TABLE 3: COMPARITIVE % DR FOR
F1, F2, F3, F4, F5 FORMULATIONS
Time (min) |
Percentage drug release (%) of
formulations |
||||
F1 |
F2 |
F3 |
F4 |
F5 |
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
44 ± 1.414 |
5 ± 7.071 |
39 ± 1.414 |
35.5 ± 0.707 |
66 ± 4.242 |
3 |
97 ± 2.828 |
33.5 ± 3.535 |
92 ± 2.828 |
82.5 ± 2.121 |
91 ± 1.414 |
5 |
98 ± 1.414 |
83 ± 2.828 |
99 ± 0 |
91 ± 1.414 |
94.5 ± 6.363 |
10 |
99.1 ± 5.656 |
103.5 ± 6.363 |
101.2 ±1.414 |
99 ± 0 |
99.1 ± 6.363 |
15 |
102.3 ± 2.828 |
103.7 ± 0.707 |
102 ± 2.828 |
103.5 ± 6.363 |
99.7 ± 0.12 |
%
DR- Percentage drug release. The data represented as mean ± SD (n- 6)
`
TABLE 4.
STABILITY STUDIES (40oC ± 2oC / 75% RH ± 5% RH)
PARAMETER |
AFTER 3rd MONTH |
||||
F1 |
F2 |
F3 |
F4 |
F5 |
|
Hardness*** (Kg/cm2) |
2.57±0.051 |
2.61±0.11 |
2.54±0.047 |
2.57±0.043 |
2.55±0.08 |
Weight variation*** (mg) |
206.6±6.65 |
204±6.24 |
205.7±6.8 |
204.3±6.8 |
206±4.58 |
Thickness* (mm) |
2.18±0.1 |
2.19±0.02 |
2.18±0.025 |
2.19±0.015 |
2.19±0.011 |
Diameter* (mm) |
1.13±0.051 |
1.1±0 |
1.1±0 |
1.1±0.005 |
1.1±0 |
Friability*** (%) |
0.79±0.045 |
0.58±0.2 |
0.65±0.025 |
0.59±0.045 |
0.7±0.028 |
Drug content**** (%) |
101.9±0.32 |
99.6±0.28 |
102.9±0.4 |
98.88±0.28 |
101.5.±0.64 |
% drug release at 15min** |
100.5±1.5 |
99.2±2.25 |
100.9±1.79 |
99.2±0.36 |
101.2±0.85 |
The date represented as mean ± SD (*n- 5, **n- 6, ***n- 10, ****n- 20)
CONCLUSION:
From the present
study, it can be concluded that natural super disintegrants
like Annona squamosa L
Leaves mucilage, Leucaena leucocephala bark gum, Moringa oleifera bark
gum and Loctus Bean gum had showed
good disintegrating property as the most widely used synthetic super disintegrants like Sodium Starch Glycolate
in the formulations of ODTs and may be used as disintegrant
in tablet formulations. As primary ingredients are cheap,
biocompatible, biodegradable and easy to manufacture. They can also be
used as superdisintegrants in place of currently
marketed synthetic superdisintegrating agents.
REFERENCES:
1.
Zatz, J.L. and G.P. Kushla; Pharmaceutical Dosage
Forms-Disperse Systems,
M. M. Reiger and G.S. Banker, Ed; Marcel
Dekker Inc., New
York.
2: 1989; pp.508.
2.
British
National Formulary ISBN 978-0-85369-776-3. 55, March 2008; pp.537.
3.
Femi- Oyewo M, Musiliu O, Taiwo O; Evaluation of
the Suspending Properties of Albizia zygia gum on Sulphadimidine
Suspension. Tropical journal of pharmaceutical Research.
4.
Vijetha Pendyala et.al., Studies On Some
Physicochemical Properties of Leucaena leucocephala Bark
Gum: Journal of Advanced Pharmaceutical Technology and Research. Vol- 1, 2010; pp.253-259.
5.
PRP Verma et.al; Studies
on Disintegrant Action of Leucaena leucocephala Seed Gum in Ibuprofen
Tablet and its Mechanism; Journal of Scientific and Industrial Research. Vol.
66, July- 2007; pp. 550- 557.
6.
Panda
D., Swain S., Gupta R., Indian J. Pharm. Sci. 68(6):
2006; pp.777-780.
7.
OECD guidelines
for testing of chemicals; 423: 17th Dec 2001.
8.
C.V.S. Subrahmanyam,
Textbook of Physical Pharmaceutics, pp. 224-227.
9.
Viral Shah et.al; Studies
on Mucilage from Hibuscus rosasinensis Linn
as Oral Disintegrant; International Journal of Applied
Pharmaceutics. Vol– 2, Issue 1: 2010; pp.18-21.
10.
Schiermeier
S, Schmidt PC. Fast dispersible ibuprofen tablets, Eur. J. Pharm. Sci. 15:
2002; pp.295‐305.
11.
Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Tarada K. Formulation design of a novel fast‐disintegrating tablet, Int
J Pharm. 306: 2005; pp.83‐90
12. B V Patel et. al; Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison With Other Superdisintegrants; International Journal of Chemtech Research. Vol. 3, No.3, July-Sept 2011; pp.
1119-1124.
13. Yunxia B, Yorinobu Y,
Kazumi D, Akinobu. O. Preparation and evaluation of
oral tablet rapidly dissolving in oral cavity. Chem. Pharm. Bull. 44(11):
1996; pp. 2121-2127.
14. Velmurugan. S and Sundar Vinushitha; Oral Disintegrating Tablets: An Overview;
IJCPS. Vol.1 (2): 2010- Dec.
Received on 21.09.2013
Modified on 02.10.2013
Accepted on 06.10.2013
© A&V Publication all right reserved
Research Journal of Pharmaceutical Dosage
Forms and Technology. 5(6): November-December, 2013, 327-333